• The Company
    Glycologic Limited utilises the unique properties of carbohydrates and
    its skill base to develop customised technology solutions to a wide
    variety of nutrition and pharmaceutical problems.

General

Based in the UK the Company has an extensive range of national and international partners with customers located throughout the world. Nutrition, over the counter (OTC) and prescription only medicine (POM or Rx) ingredients used in many healthcare products have been developed by the Company and act to optimise health and protect against disease.


Blood Clotting

Blood Clotting

Under development

Buccal (Mouth) Delivery

Buccal (Mouth) Delivery

Under development

Diagnostics

Diagnostics

Wound infection diagnostic kit will complete clinical trials in NHS December 2019/January 2020.

 

Digestion (Large Intestine)

Digestion (Large Intestine)

Fibre. Prebiotics and probiotics.

Digestion (Small Intestine)

Digestion (Small Intestine)

Control of nutrient absorption. Energy control (fast and controlled release of energy). Satiety. Weight management.

Dressings and Wound Care

Dressings and Wound Care

Wound infection diagnostic kit will complete clinical trials in NHS December 2019/January 2020.

Energy and Blood Glucose Control

Energy and Blood Glucose Control

Energy control in health and disease. Control and utilisation of digestible carbohydrates.

Gastric (Stomach) Health

Gastric (Stomach) Health

Under development

Immunity and Infection

Immunity and Infection

Under development

Liver and In-Born Errors of Metabolism

Liver and In-Born Errors of Metabolism

Glycogen storage and mobilisation. In-born errors of metabolism and liver disease.

Oral Care

Oral Care

Under development

Skin and Topical

Skin and Topical

Under development

Vaginal Health

Vaginal Health

 Under development